Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The primary objective of this study was to investigate patients acceptability / preference of Berodual® Respimat® inhaler as compared to the conventional Berodual® Metered Aerosol (MA) inhaler. Ease of handling and assembling the Respimat® inhaler at home under real life conditions was also evaluated.
Epistemonikos ID: afc46257629a0d90063aa21a55716ed6c76b8790
First added on: May 11, 2024